CA
NZ
UK
AU
IND
US
Healthcare investing is currently at a crossroads as artificial intelligence technologies evolve, prompting significant shifts in market dynamics. Investors are increasingly questioning the viability of traditional healthcareInvestmentstrategies as they assess the growing impact of AI on the sector. This trend has created a palpable …
AIM ImmunoTech Inc. reported an EPS of $-0.43 for Q2 2026, falling short of the consensus estimate by $0.26. This poor performance highlights ongoing challenges for investors in a company with a marketCapitalizationof approximately $8 million.Key HighlightsThis substantial deviation underscores ongoing operational challenges that …
Positive Clinical Outcomes for PLICID
Silence Therapeutics (NASDAQ:SLN) shares were trading at $15.77 in pre-market activity on August 11, 2026, up 2.20% from the prior close of $15.43, building on a 29.12% surge in the prior regular session after the company announced positive topline results from its Phase 2 …
Tactile Systems Technology (NASDAQ:TCMD) shares were trading at $23.80 in pre-market activity on August 11, 2026, down 18.33% from the prior close of $29.14. The decline came despite the company beating both revenue andEarningsestimates for the second quarter of 2026, with revenue of $85.7 …
Alumis Inc. (NASDAQ:ALMS) reported topline results from its ONWARD3 long-term extension study, showing that its investigational oral therapy envudeucitinib delivered the highest reported PASI 100 complete skin clearance rate among existing and investigational oral therapies for moderate-to-severe plaque psoriasis. Envudeucitinib is a next-generation oral …
Autolus Therapeutics (NASDAQ:AUTL) shares were trading at $2.15 in pre-market activity on August 11, 2026, up 3.86% from the prior close of $2.07. The move extended recent momentum following the company's second quarter results, which significantly beat expectations: an EPS loss of $(0.15) came …
Baird Medical (NASDAQ:BDMD) shares were trading at $1.27 in pre-market activity on August 11, 2026, up 4.10% from the prior close of $1.22. The move followed the company's announcement of a strategic cooperation agreement with Alpmed, a China-based innovator in irreversible electroporation technology, to …
Harrow (NASDAQ:HROW) shares were trading at $38.63 in pre-market activity on August 11, 2026, down 5.09% from the prior close of $40.70. The decline followed second quarter 2026 results in which revenue of $70.7 million grew 60% sequentially and 11% year over year, but …
Hims & Hers Health (NYSE:HIMS) shares were trading at $30.30 in pre-market activity on August 11, 2026, down 4.63% from the prior close of $31.77. The decline came at a mixed second quarter print: revenue of $753.2 million beat the $752.3 million estimate, and …
Please wait processing your request...